vimarsana.com

Latest Breaking News On - Acute optic neuritis - Page 1 : vimarsana.com

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

ZUG, Switzerland, May 30, 2024 Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members.

Texas
United-states
Germany
Switzerland
California-institute-of-technology
California
San-diego
Brazil
Armenia
Bonn
Nordrhein-westfalen
London

Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis

Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Paris
France-general
France
Iceland
United-states
Pablo-villoslada
Corey-davis
Sophie-bonnin

Oculis Announces Completion Of Enrollment In Phase 2 Randomized Controlled ACUITY Trial With OCS-05 For ...

Oculis Announces Completion Of Enrollment In Phase 2 Randomized Controlled ACUITY Trial With OCS-05 For ...
wn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wn.com Daily Mail and Mail on Sunday newspapers.

Acute-optic-neuritis

Nasdaq Iceland welcomes Oculis to the Main Market

Nasdaq Iceland welcomes Oculis to the Main Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Copenhagen
Køavn
Denmark
Helsinki
Eteläuomen-läi
Finland
Stockholm
Sweden
Switzerland
Iceland
Magnus-hardarson
Dennis-riedl

Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery

Oculis Announces First Patient First Visit in Phase 3 OPTIMIZE-2 Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Boston
Massachusetts
United-states
Eric-donnenfeld
Sylvia-cheung
Lifesci-advisorscorey-davis
Oculis-holding
Oculis-holding-ag-nasdaq
Exchange-commission
Nasdaq
Drug-administration
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.